***Background.*** To address the lack of US specialists available to care for the estimated 2.7 million persons with chronic hepatitis C virus (HCV) infection, CDC supports training of primary care providers and technology to offer remote treatment options. We evaluated the distance patients travelled to visit the provider ordering HCV tests.

***Methods.*** A new private-public partnership allowed for preliminary analysis of LabCorps testing records conducted during February -- July 2012. HCV-related tests consisted of antibody, nucleic acid (RNA and genotype) and host IL28B tests. We calculated the frequency and distribution of tests by test type, and the ratio of number of tests and unique providers by provider specialty. We used SASHELP.zipfile to estimate the distance between the center of the patient zipcode and the center of the provider zipcode to compare median distances by provider specialty and US state.

***Results.*** CDC received records from 1,112,105 tests conducted by LabCorps during the 6 month period. Of these, 83% (926,805) were antibody tests, 16% (178,020) were nucleic acid tests, and \<1% (7,276) were IL28B tests; 981,078 tests ordered by 120,721 providers had complete information. The test to provider ratio was 8.1 overall and was higher for infectious diseases (23.7) and hepatology (26.1) specialists compared with primary care providers (family practice, 6.4; general practice, 6.6; internal medicine, 7.3). For 571,356 records, the median distance between patient and provider zipcodes was 12.1 miles. The median distance patients travelled did not differ by type of test; 12.0 miles for an antibody test and 12.4 miles for a nucleic acid test. However, the median distance to see a primary care provider was shorter (internal medicine 8.0 miles, general practice 10.0 miles, and family practice 11.5 miles) compared to the median distance travelled to see a gastroenterologist or hepatologist (12.4 miles, and 22.7 miles, respectively).

***Conclusion.*** Patients were closer in proximity to primary care providers and if these can be trained to test and provide care and treatment, then more infected persons could be helped.
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